Protein adenosine diphosphate (ADP)-ribosylation is crucial for a proper immune response. Accordingly, viruses have evolved ADP-ribosyl hydrolases to remove these modifications, a prominent example being the SARS-CoV-2 NSP3 macrodomain, "Mac1". Consequently, inhibitors are developed by testing large libraries of small molecule candidates, with considerable success. However, a relatively underexplored angle in design pertains to the synthesis of structural substrate mimics. Here, we present the synthesis and biophysical activity of novel adenosine diphosphate ribose (ADPr) analogues as SARS-CoV-2 NSP3 Mac1 inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249776 | PMC |
| http://dx.doi.org/10.1021/acs.orglett.4c01792 | DOI Listing |
Publication Analysis
Top Keywords
synthesis structural
8
adenosine diphosphate
8
sars-cov-2 nsp3
8
structural adp-ribose
4
adp-ribose analogues
4
analogues inhibitors
4
inhibitors sars-cov-2
4
sars-cov-2 macrodomain
4
macrodomain protein
4
protein adenosine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!